ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 41 - 50 of 63
Presenter(s): Victoria A Sanchez, AuD, PhD, CCC-A, F-AAA; Ann Clock Eddins, PhD, MBA, CCC-A, FAAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Emerging treatment approaches for age-related hearing loss include alternative interventions aimed at ameliorating symptoms and slowing down or even preventing hearing loss, in contrast with current treatment approaches, which focus primarily on amplification and communication strategies. This session will explore up-and-coming approaches, such as pre-clinical investigation of hormones (e.g., Aldosterone) correlated with auditory function; medicinal-related interventions; and challenges to timelines to bring new treatments to market.
Presenter(s): Amyn M. Amlani, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The degree of hearing aid adoption as a treatment to lessen communication difficulties has remained essentially unchanged over the past four decades. This session will share evidence and hands-on tools that promote opportunities for evaluating and modifying patient readiness, with the intent of enhancing the adoption of professional audiology services and amplification technologies.
Presenter(s): Dave Fabry, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is no question that emerging technologies such as embedded sensors and artificial intelligence are changing the hearing health landscape. This session will look ahead to the coming decade and explore innovations in hearing health care technology, strategy, and service. The speaker will discuss practical ways to leverage these innovations to be successful in today’s and tomorrow’s dynamic market landscape.
Presenter(s): Devin L. McCaslin, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session will examine the diagnosis and treatment of persistent postural-perceptual dizziness (PPPD). The session will explore the recently defined criteria for the presentation and symptoms of the disorder as well as describe current and emerging research that is helping clinicians and researchers better understand it. The speaker will also discuss how chronic co-morbid disorders such as migraine and Meniere’s disease should be factored into the treatment of this disorder.
Presenter(s): Jennifer Braswell Christy, PT, PhD; Violette H Lavender, AuD; Sharon Cushing
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session addresses the management of pediatric vestibular and balance disorders. Particular focus is paid to the characteristics of pediatric patients who would likely benefit from vestibular and balance therapy, the focus of such therapy, and the types of exercises done to target vestibular-related impairments in children.
Presenter(s): Steven Thomas Kulsar, PhD, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session focuses on the use of in-situ measures and development of patient amplification prescriptions. The importance of in-situ measures is widely overlooked or misunderstood. Dissecting the benefits of this and other built-in manufacturer software features will provide opportunity for significant improvement in fitting outcomes and patient satisfaction over conventional first-fit settings.
Presenter(s): Sharon Cushing; Jennifer Braswell Christy, PT, PhD; Violette H Lavender, AuD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session addresses the diagnosis of pediatric vestibular and balance disorders. Particular focus is paid to the most common audiological testing accommodations for pediatric patients suffering from dizziness and imbalance as well as the etiologies of such disorders seen in the pediatric population.
Presenter(s): Pamela E Souza, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: According to recent research, an individual's success with using a hearing aid is connected to their cognitive ability. This course reviews the evidence and explains how to apply it to clinical decision-making to improve outcomes for each individual patient.
Presenter(s): Mark A. Parker, PhD, CCC-A, F-AAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The audiogram is a poor representation of a person's underlying otopathology and can therefore be a poor predictor of a person's hearing impairment. For example, persons with audiometric thresholds within normal limits may experience hearing impairment such as difficulty hearing in noise. Cochlear synaptopathy and outer hair cell dysfunction are two otopathologies undetected by the standard audiogram (a.k.a. Hidden Hearing Loss), but outer hair cell function plays a primary role in hearing in noise performance. A third undetected otopathology is cochlear untuning, which occurs secondary to outer hair cell damage. This course discusses each of these otopathologies and presents clinical normative data that can be used to differentially diagnose each otopathology.
Presenter(s): Meaghan Reed, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: It is unclear how over-the-counter hearing devices will impact our patients and our practices in the coming years. This session will discuss practical strategies for incorporating OTC devices, deciding when to offer alternative rehabilitation options to patients, and offering a wider variety of solutions to meet our patients’ needs.
<< 1 2 3 4 5 6 7 >>